PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,099,000 | -31.2% | 971,800 | 0.0% | 0.03% | -25.6% |
| Q2 2019 | $3,051,000 | -15.6% | 971,800 | 0.0% | 0.04% | -13.3% |
| Q1 2019 | $3,615,000 | +28.3% | 971,800 | 0.0% | 0.04% | +21.6% |
| Q4 2018 | $2,818,000 | +10.3% | 971,800 | 0.0% | 0.04% | +48.0% |
| Q3 2018 | $2,556,000 | +1.9% | 971,800 | -9.3% | 0.02% | 0.0% |
| Q2 2018 | $2,508,000 | +0.2% | 1,071,800 | +25.9% | 0.02% | -7.4% |
| Q1 2018 | $2,502,000 | +7.3% | 851,000 | 0.0% | 0.03% | +8.0% |
| Q4 2017 | $2,332,000 | +1271.8% | 851,000 | +1602.0% | 0.02% | +1150.0% |
| Q3 2017 | $170,000 | +37.1% | 50,000 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $124,000 | +8.8% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $114,000 | +7.5% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $106,000 | -93.4% | 50,000 | -89.5% | 0.00% | -95.8% |
| Q3 2016 | $1,603,000 | +6.7% | 478,400 | 0.0% | 0.02% | +4.3% |
| Q2 2016 | $1,502,000 | -5.7% | 478,400 | 0.0% | 0.02% | -14.8% |
| Q1 2016 | $1,593,000 | -6.0% | 478,400 | 0.0% | 0.03% | -15.6% |
| Q4 2015 | $1,694,000 | -13.2% | 478,400 | +23.3% | 0.03% | -22.0% |
| Q3 2015 | $1,952,000 | -23.0% | 388,100 | -1.6% | 0.04% | -18.0% |
| Q2 2015 | $2,536,000 | -9.2% | 394,400 | -0.7% | 0.05% | -13.8% |
| Q1 2015 | $2,794,000 | +5.8% | 397,200 | +16.0% | 0.06% | -3.3% |
| Q4 2014 | $2,641,000 | +12.2% | 342,500 | +8.7% | 0.06% | +1.7% |
| Q3 2014 | $2,354,000 | -21.0% | 315,180 | +2.4% | 0.06% | -24.4% |
| Q2 2014 | $2,979,000 | +14.0% | 307,700 | -2.1% | 0.08% | +4.0% |
| Q1 2014 | $2,613,000 | -3.3% | 314,400 | -1.8% | 0.08% | -8.5% |
| Q4 2013 | $2,703,000 | +13.8% | 320,300 | +7.4% | 0.08% | +1.2% |
| Q3 2013 | $2,376,000 | +19.1% | 298,100 | +15.3% | 0.08% | +1.2% |
| Q2 2013 | $1,995,000 | – | 258,450 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |